Contravisory Investment Management’s C.H. Robinson CHRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
6,164
+167
+3% +$29.7K 0.21% 91
2026
Q1
$996K Sell
5,997
-6
-0.1% -$1.07K 0.2% 86
2025
Q4
$965K Buy
+6,003
New +$887K 0.19% 77
2025
Q3
Sell
-7,799
Closed -$748K 373
2025
Q2
$748K Buy
7,799
+2,547
+48% +$239K 0.15% 97
2025
Q1
$538K Sell
5,252
-1
-0% -$101 0.11% 134
2024
Q4
$543K Buy
+5,253
New +$565K 0.12% 119
2023
Q1
Sell
-4,867
Closed -$446K 331
2022
Q4
$446K Buy
4,867
+613
+14% +$58.4K 0.12% 104
2022
Q3
$410K Buy
4,254
+639
+18% +$68.7K 0.14% 86
2022
Q2
$366K Buy
3,615
+4
+0.1% +$418 0.12% 107
2022
Q1
$389K Buy
+3,611
New +$367K 0.11% 121
2021
Q1
Sell
-3,513
Closed -$330K 268
2020
Q4
$330K Sell
3,513
-413
-11% -$39.4K 0.1% 107
2020
Q3
$401K Buy
3,926
+451
+13% +$42.3K 0.14% 78
2020
Q2
$271K Buy
+3,475
New +$262K 0.1% 119
2016
Q3
Sell
-45
Closed -$3K 288
2016
Q2
$3K Buy
+45
New +$3.29K ﹤0.01% 141

Other funds holding CHRW

Contravisory Investment Management's CHRW Position: Q2 2026 in Review

Contravisory Investment Management increased its C.H. Robinson (CHRW) stake by 2.8% in Q2 2026, buying an estimated $29.7K and bringing the position to 6,164 shares worth $1.16M. The position accounts for 0.21% of the portfolio, ranked #91.

Contravisory Investment Management first reported a position in CHRW in Q2 2016 and has held it in 14 quarters since. 889 funds tracked by Wall St. Rank hold CHRW as of Q2 2026.

  • Contravisory Investment Management held 6,164 shares of C.H. Robinson worth $1.16M as of Q2 2026.
  • Contravisory Investment Management bought 167 C.H. Robinson shares in Q2 2026, an estimated $29.7K.
  • C.H. Robinson made up 0.21% of Contravisory Investment Management's portfolio in Q2 2026, its #91 holding.
  • Contravisory Investment Management first reported a position in C.H. Robinson in Q2 2016 and has held it in 14 quarters since.
  • 889 funds tracked by Wall St. Rank held C.H. Robinson as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.